A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both...

Nov 6, 2009
 

Background:Although tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising agent for human cancer therapy, prostate cancer still remains resistant to TRAIL. Both X-linked inhibitor of apoptosis (XIAP)... [read full story]                    

powered by
Add Comment
View all news articles about*:
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies